MedTrace Logo

Near Infrared Spectroscopy (NIRS) in Severe Sepsis

NCT00167596 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2016-07-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the usefulness of an optimization of muscle perfusion and oxygenation, as assessed by the NIRS technique, in critically ill patients with sepsis.

Conditions

  • Critical Illness
  • Severe Sepsis

Interventions

DEVICE

Near Infrared Spectroscopy

resuscitation will be based on Surviving Sepsis Campaign guidelines AND on increasing StO2 to 80% or more in at least 2 out of the 3 following sites: thenar, masseter and deltoid

DEVICE

conventional

resuscitation will be based according to Surviving Sepsis Campaign

Sponsors & Collaborators

  • Hutchinson Technology Inc

    collaborator INDUSTRY

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • University of Versailles

    lead OTHER

Principal Investigators

  • Djillali Annane, MD, PhD · Raymond Poincaré Hospital, AP-HP

  • Olivier Nardi, MD · Raymond Poincaré Hospital, AP-HP

  • Gwenhael Colin, MD · Raymond Poincaré Hospital, AP-HP

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2009-05-31
Completion
2009-12-31

Countries

  • France
  • Germany
  • Greece
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167596 on ClinicalTrials.gov